R. De Coster

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 4.8K citations

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 1.4K citations

Hypertension, Pharmacotherapy, Blood Pressure +16

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects

May‐Lynn Huang, Achiel Van Peer, Robert Woestenborghs et al. · Clinical Pharmacology & Therapeutics · 1993 · 316 citations

Medicinal Chemistry, Healthy Subjects, Psychiatry +14

Prolactin Levels and Adverse Events in Patients Treated with Risperidone

David L. Kleinberg, John M. Davis, R. De Coster et al. · Journal of Clinical Psychopharmacology · 1999 · 306 citations

Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 303 citations

Hypertension, Cost Effectiveness Ratios, Cost Effectiveness Analysis +19